Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers from the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) have found that increased exposure to bright sunlight may be associated with a lower risk of type 2 diabetes and heart disease by lowering blood insulin and triglyceride levels.

The study, published in the Journal of Clinical Endocrinology & Metabolism, is the first to suggest that regular exposure to bright sunlight might improve glucose and fat metabolism.

A team of researchers led by Dr Costas Christodoulides and Professor Fredrik Karpe from the Radcliffe Department of Medicine examined data from local weather stations coupled with blood and body fat measurements from over 10,000 healthy middle-aged people from the Oxford Biobank and the Netherlands Epidemiology of Obesity studies – these are large-scale databases of health information from volunteers living in Oxfordshire, UK, and Leiden, Netherlands. The Oxford team worked closely with colleagues at the Leiden University Medical Centre in the Netherlands for this study.

Read more (Radcliffe Department of Medicine website)

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.